Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-014614
Filing Date
2023-03-02
Accepted
2023-03-02 16:10:06
Documents
1
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7999
  Complete submission text file 0001209191-23-014614.txt   9337
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
Davis George Eric (Reporting) CIK: 0001380710 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 23699003